Photo: Theron Wallis, CC BY-SA 4.0, via Wikimedia Commons

Jeffrey M. Leiden

Executive Chairman at Vertex Pharmaceuticals Incorporated · b. 1955

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
4 years
Director since
2023

4 years of board service in total across 2 boards, counting each seat separately. Longest: Vertex Pharmaceuticals Incorporated, 3 years.

Vertex Pharmaceuticals Incorporated Director · Executive Chairman
3 years · Since 2023
6 months · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
May 11, 2026 Odyssey Therapeutics Inc. Derivative conversion +28,698 — —
May 11, 2026 Odyssey Therapeutics Inc. Option exercise +2,963 — —
May 11, 2026 Odyssey Therapeutics Inc. Shares withheld for tax −17 $18.00 $306
May 8, 2026 Odyssey Therapeutics Inc. Open-market purchase +5,000 $20.00 $100,000
Feb 24, 2026 Vertex Pharmaceuticals Incorporated Shares withheld for tax −3,547 $485.11 $1,720,685
Feb 18, 2026 Vertex Pharmaceuticals Incorporated Shares withheld for tax −2,964 $483.75 $1,433,835
Feb 17, 2026 Vertex Pharmaceuticals Incorporated Grant or award +8,269 — —
Jan 22, 2026 Vertex Pharmaceuticals Incorporated Grant or award +9,012 — —
Dec 4, 2025 Vertex Pharmaceuticals Incorporated Option exercise +1 $91.05 $91
Dec 3, 2025 Vertex Pharmaceuticals Incorporated Option exercise +63,781 $86.52 $5,518,332
Dec 3, 2025 Vertex Pharmaceuticals Incorporated Open-market sale −4,469 $440.40 $1,968,148
Dec 3, 2025 Vertex Pharmaceuticals Incorporated Open-market sale −1,320 $441.26 $582,463
Dec 3, 2025 Vertex Pharmaceuticals Incorporated Open-market sale −2,469 $443.21 $1,094,285
Dec 3, 2025 Vertex Pharmaceuticals Incorporated Open-market sale −4,352 $444.36 $1,933,855
Dec 3, 2025 Vertex Pharmaceuticals Incorporated Open-market sale −7,899 $445.56 $3,519,478

Questions about Jeffrey M. Leiden

What boards is Jeffrey M. Leiden on?

Jeffrey M. Leiden sits on the boards of Odyssey Therapeutics Inc. and Vertex Pharmaceuticals Incorporated.

How long has Jeffrey M. Leiden served on boards?

Our records show at least 4 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.